PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Outlook Therapeutics Reports EMA's Validation of MAA for ONS-5010 to Treat Wet AMD

Outlook Therapeutics Reports EMA's Validation of MAA for ONS-5010 to Treat Wet AMD

December 23, 2022

PharmaShots Weekly Snapshots (December 19 - 23, 2022)

PharmaShots Weekly Snapshots (December 19 - 23, 2022)

December 23, 2022

BridgeBio Pharma Initiates P-III Study (CALIBRATE) of Encaleret for Autosomal Dominant Hypocalcemia Type 1

BridgeBio Pharma Initiates P-III Study (CALIBRATE) of Encaleret for Autosomal Dominant Hypocalcemia Type 1

December 23, 2022

$Genentech’s Lunsumio (mosunetuzumab-axgb) Receives the US FDA’s Approval for Relapsed or Refractory Follicular Lymphoma$

Genentech’s Lunsumio (mosunetuzumab-axgb) Receives the US FDA’s Approval for Relapsed or Refractory Follicular Lymphoma

December 23, 2022

Merck Signs a Research Collaboration and Commercial License Agreement with Mersana for Novel Antibody-Drug Conjugates

Merck Signs a Research Collaboration and Commercial License Agreement with Mersana for Novel Antibody-Drug Conjugates

December 23, 2022

Eli Lilly Expands its 2021 Agreement with ProQR Therapeutics for New Genetic Therapies

Eli Lilly Expands its 2021 Agreement with ProQR Therapeutics for New Genetic Therapies

December 23, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us